Skip to content

Clinical trials

Phase 2/3 Metabolic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 2/3 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20071
20084
20094
20111
20122
20131
20143
20151
20162
20172
20181
20192
20201
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Unknown status3
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Sciences3
Joslin Diabetes Center3
National Nutrition and Food Technology Institute3
University of Guadalajara2
University of Messina2
Ain Shams University1
Brigham and Women's Hospital1
Chonbuk National University Hospital1
Chung Shan Medical University1
Jaime Daniel Mondragon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome34
Diabetes Mellitus, Type 24
Inflammation4
Obesity4
Insulin Resistance3
Overweight3
Glucose Intolerance2
Schizophrenia2
Atherosclerosis1
Cardiovascular Diseases1

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.